ChartRow logo
ChartRow
Investing Charts
VRTX
Vertex Pharmaceuticals IncorporatedStock · HealthcareNasdaq-100 0.6% · S&P 500 0.2%
$477.37+$4.28 (+0.90%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

VRTXVertex Pharmaceuticals Incorporated stock price, chart and key statistics

Key stats

Price data

Price
$477.37
Change YTD
+5.58%
Next earnings
Aug 3, 2026 · After close
Market cap
121.2B
Enterprise value
115.8B
Shares outstanding
253.8M
52W low
$362.50
52W high
$533.67
From 52W high
-10.55%
From 52W low
+31.69%
52W range
67%
Beta
0.29

Volume

Rel volume
0.98×
30D volume
1.8M
30D $ vol
849M

Fundamentals

Sales (ttm)
12.2B
Sales/share
$48.14
EPS (ttm)
$16.93
FCF (ttm)
3.7B
FCF/share
$14.62
Book value/share
$76.29
Net margin
35.51%
ROE
22.41%
ROA
16.38%
Debt / equity
0.01×
Current ratio
3.02

Growth (CAGR, ttm) · 10Y

Sales
+25.20%
Net income
n/a
FCF
n/a
Shares
+0.26%

Per-share growth (CAGR, ttm) · 10Y

EPS
n/a
Sales/share
+24.87%
FCF/share
n/a
Book value/share
+34.74%
Price
+17.65%
Total return
+17.65%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
27.9×
Fwd P/E
22.3×
P/S (ttm)
9.9×
P/B (mrq)
6.3×
P/FCF (ttm)
32.7×
EV/EBITDA (fy)
26.4×
EV/Sales (ttm)
9.5×
FCF yield (ttm)
3.06%
Buyback yield (ttm)
1.59%
Shareholder yield (ttm)
1.59%

Vs own 10Y history

P/E
55th
P/S
39th
P/B
33rd
P/FCF
53rd

Bar = where today's multiple sits in VRTX's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
+0.90%
1W
-1.70%
1M
+0.46%
3M
+9.71%
YTD
+5.58%
1Y
+0.09%
5Y
+135.99%

Financial statements

Open full VRTX financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,196+7.05%3.2B
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
ABBV
AbbVie Inc.
Biopharma$259+10.36%1.9B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
MRK
Merck & Co. Inc.
Pharmaceuticals$131+8.70%1.3B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
AMGN
Amgen Inc.
Biotech$376+7.00%969.4M
ABT
Abbott Laboratories
Medical Devices$103+13.95%1.3B

Vertex Pharmaceuticals Incorporated (VRTX) trades at $477.37 with a live price and an interactive chart covering 35+ years of daily price history, plus key valuation metrics. ChartRow also publishes VRTX's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full VRTX financial statements →